Objectives: This study aims to detect the maximum permissible activity (MPA) in patients with unresectable liver metastasis and hepatocellular carcinoma treated with Yttrium-90 (Y-90) microspheres and to evaluate the absorbed radiation doses with patient-specific dosimetry methods. Materials and methods: A total of 31 patients (20 males, 11 females; mean age 47±0.2 years; range, 32 to 62 years) were applied dosimetry. Empiric, body surface area (BSA), Medical Internal Radiation Dose (MIRD) and partition internal dosimetry models were used to calculate the MPA to deliver the maximum absorbable dose to the tumor while reducing the absorbed dose by the critical organs. Results: Mean Y-90 activity was 57483±7.7 megabecquerel (MBq) for empiric model, 1806.04±1.37 MBq for BSA, 1649.60±1.3 MBq for MIRD, and 1658.71 MBq for partition. Mean absorbed dose calculated according to empiric model was 40.14±0.20, 197.62±0.45 and 7.39±0.08 gray (Gy) for normal liver, tumor and lung, respectively. Mean absorbed dose calculated according to BSA was 33.61±0.18, 167.83±0.41, 6.39±0.08 Gy for normal liver, tumor and lung, respectively. Mean absorbed dose calculated according to MIRD was 29.63±0.17, 125.62±0.36 and 5.67±0.07 Gy for normal liver, tumor and lung, respectively. Mean absorbed dose calculated according to partition model was 29.82±0.17, 126.72±0.36 and 5.72±0.07 Gy for normal liver, tumor and lung, respectively. Conclusion: Since the MPAs calculated according to empiric and BSA models will lead to organ toxicity by forming high amounts of absorbed doses at critical organs, these models are not appropriate approaches for dosimetry. On the other hand, MIRD and partition models are the most successful methods for internal dosimetry applications.
Since there are two different arteries supplying blood to the liver and 80-100% of tumor cell's blood nourishment flow from the right hepatic artery, [1] the directed transarterial perfusion of radioactive microspheres leads to serious damage in unresectable tumors, which consequently increase morbidity and mortality. [2] [3] [4] [5] [6] [7] The widespread use of radioembolization requires debates on the amount of the optimal dose to be delivered to the patient similar to radiotherapy where the main purpose is to maximize the dose absorbed by tumor tissues and to reduce the dose absorbed by normal tissues. Possible vascular shunting from the hepatic artery to the lung will increase risks for lung irradiation and occurrence of lung tissue damage. Predosimetry is highly recommended to calculate the maximum permissible activity (MPA) of Yttrium-90 (Y-90) taking into account the optimum effective dose for the tumor tissue and safe low doses for critical organs such as lungs and normal liver tissue to protect them from exposure to radiation and cellular toxicity.
According to previous publications on radiotherapy, the maximum tolerable dose has been limited to 35 gray (Gy) on the condition that the liver/tumor uptake ratio does not exceed 30%, [8] and lung absorbed dose is up to 12 Gy. [9] It is well-known that Y-90 is a high-energy beta-emitter that may damage normal tissues of the liver and lungs. Shunting among lungs and liver, which opens a passage for microspheres to leak inside the lungs, may cause significant impairment in the lung tissue. Therefore, prior to Y-90 radioembolization, therapy simulation using technetium 99mTc macro aggregated albumin (Tc-99m-MAA) is recommended for pre-dosimetry to confirm the administered activity that would accumulate in the target tumor and limit the absorbed doses by normal liver tissue and lungs. Thus, in this study, we aimed to detect the MPA in patients with unresectable liver metastasis and hepatocellular carcinoma treated with Y-90 microspheres and to evaluate the absorbed radiation doses with patient-specific dosimetry methods.
MATERIALS AND METHODS
The study was conducted at ‹stanbul University, Cerrahpaa Medical Faculty between February 2012 and June 2014 and included 31 patients (20 males, 11 females; mean age 47±0.2 years; range, 32 to 62 years) who underwent predosimetry to determine MPA to ensure successive treatment with no side effects to the critical organs. Patients' mean height was 1.6±0.04 m, mean weight was 73.6±0.2 kg, mean tumor volume was 355.2±0.6 cm 3 , and mean liver volume was 1,942.2±1.4 cm 3 . The study protocol was approved by the ‹stanbul University, Cerrahpaa Medical Faculty Ethics Committee. A written informed consent was obtained from each patient. The study was conducted in accordance with the principles of the Declaration of Helsinki.
Dosimetry models

Empiric model
The empiric method suggests a standard amount of activity given in accordance with the tumor size in the liver. The applicable amount of standard activity for liver and tumor volumes has been shown in detail. [10] Body surface area model Body surface area (BSA) is a new version of empiric method. It is basically calculated using the weight (kg) and height (m) values of the patient. [11] Medical internal radiation dose model Medical Internal Radiation Dose (MIRD) model application dictates presence of essential parameters, for instance liver and tumor mass, normal liver tissue and tumor uptake in order to calculate absorbed dose of normal liver and tumor as reported by Gulec at al. [12] On the other hand, the MPA of Y-90 intended to be applied may be consistent with the prescribed tolerable dose of the liver and lungs:
To evaluate the m liver parameter, total liver volume was calculated over computed tomography scan using OsiriX software (Pixmeo, Switzerland) and then multiplied by soft tissue density. [13] To evaluate the m tumor parameter, the Cavalieri principle was used. This principle is considered an accurate method to calculate the volume of DOSEliver (rad)= Activitytotal (mCi)¥184,000¥UPTAKEliver
Eq.1 mliver (g) DOSEtumor (rad)= Activitytotal (mCi)¥184,000¥UPT TLRtumor Eq.2 mtumor (g) DOSElungs (rad)= Activitytotal (mCi)¥184,000¥SF Eq.3 mlungs (g) irregular objects [10, [14] [15] [16] with reliable geometric data obtained from patients' Tc-99m-MAA singlephoton emission computed tomography images for tumors.
The formation of arteriovenous connection with pulmonary system produces lung shunting involving a flow of microspheres into the inner layers of lungs exposing it to radiation. Thus, the fraction of Tc-99-MAA leaking into lungs is typically estimated by drawing a region of interest over the lungs and liver on the planar images as shown in the following function: [12] For a patient to be accepted ideal and appropriate to undergo Y-90 radioembolization, the lung shunting fraction (SF) must not exceed 20%. [15] To assess tumor to liver uptake ratio plays a major role in accomplishing Y-90 MPA, in which the borders of tumor and normal liver are pointed out optically and tumor/liver ratio (TLR) is determined as: [17] SF= Countslungs Eq.4 Countslungs+Countsliver 
Partition model
In the partition model, the radiation dose of a functional organ with a mass of m (g) and an activity of A 0 (GBq) is calculated using the MIRD principles with a simplification. [18] 
Statistical analysis
Microsoft Excel 2010 software was used for statistical analysis.
RESULTS
The amount of activity determined by the empiric model and the normal liver, tumor and lung doses to be formed are shown in Table 1 . Mean normal liver, mean tumor, and mean lung doses were calculated as 40.14±0.20 Gy, 197.62±0.45 Gy, and 7.39±0.08 Gy, respectively, when mean 57,483±7.7 megabecquerel (MBq) activity was given according to empiric model. Normal liver doses shown in Table 1 were found to be well above the reference liver dose. [19] Lung dose limit [20] exceeded in one patient. tumor/liver ratio (TLR)= Maximum tumor counts Eq.5 Liver average counts The amount of activity determined by the BSA model and the normal liver, tumor and lung doses to be formed are shown in Table 2 . Mean normal liver, mean tumor, and mean lung doses were 33.61±0.18 Gy, 167.83±0.41 Gy, and 6.39±0.08 Gy, respectively, when mean 1,806.04±1.37 MBq activity was given according to the BSA model. Normal liver doses shown in Table 2 were found to be well above the reference liver dose. [19] Lung dose limit [20] exceeded in one patient. The quantities of activity planned for the BSA model produced high radiation doses in critical organs.
The amount of activity determined by the MIRD model and the normal liver, tumor and lung doses to be formed are shown in Table 3 . When mean 1,649.60±1.31 MBq activity was given according to the MIRD model, mean normal liver, mean tumor, and mean lung doses were calculated as 29.63±0.17 Gy, 125.62±0.36 Gy, and 5.67±0.07 Gy, respectively. Normal liver doses shown in Table 3 were close to the reference liver dose. [19] No radiation doses exceeded the maximum dose of 12 Gy for the lungs. [20] The amount of activity determined by the partition model and the normal liver, tumor and lung doses to be formed are shown in Table 4 . Mean normal liver, mean tumor, and mean lung doses were 29.82±0.17 Gy, 126.72±0.36 Gy, and 5.72±0.07 Gy, respectively, when mean 1,658.72±1.31 MBq activity was given according to the partition model. The doses indicated in bold in Table 4 exceeded the maximum accepted 30-35 Gy liver dose. [19] No radiation dose exceeded the maximum dose of 12 Gy for the lungs. [20] 
DISCUSSION
In this study, we aimed to perform patientspecific radiation dosimetry to determine the parameters required for the diagnosis of primary or metastatic liver cancer for an effective treatment.
In the field of Y-90 microspheres therapy, a great number of dosimetric models have been developed gradually starting from empiric, BSA, MIRD and partition models, and finally Monte Carlo simulation. [12, [21] [22] [23] [24] [25] When MPA values calculated with empiric model were given to patients, liver absorbed dose was higher than 30-35 Gy in 18 patients. Moreover, there was one patient whose lung absorbed dose was above the reference dose. With empiric model, the calculated MPA will deliver large absorbed doses to the critical organs, leading to organ toxicity in late stages. Therefore, we concluded that empiric model is not an appropriate dosimetry approach. Additionally, it does not allow patient-specific dosimetry.
Regarding MPA determined by the BSA model, the liver absorbed dose was higher in eight patients, and the lung absorbed dose was above the reference dose in one patient. Consequently, BSA model failed to be a suitable dosimetry model due to the calculated high absorbed doses that cause organ toxicity.
Since MIRD and partition models are mainly based on more scientific regulations compared to the previous models, they have great advantages to promote optimum Y-90 dosimetry. [11] The tumor, liver, and lungs masses, SF, TLR, and liver and tumor uptakes are the most essential parameters needed to achieve precise calculations for MPA of Y-90. Moreover, our cases did not have any dose higher than the reference doses. When the SF is high, it can keep the absorbed dose of lungs within the acceptable limits. Additionally, there is no theoretical limit for calculated activity.
In all dosimetry models used, it is assumed that the amount of activity given for treatment is homogeneously distributed throughout the tumor. However, it is known that dead areas such as necrosis may be present in the tumor. In addition, necrosis areas were ignored while tumor volume was calculated. In the next study, it is aimed to do dosimetry with the Monte Carlo method, which gives new and near-realistic results to remove all these limitations.
In conclusion, MIRD and partition models were found to be optimal dosimetry models. Based on the mean normal liver and lung dose values in our study, the amount of activity planned to be given according to the MIRD model has produced radiation doses that can be tolerated in critical organs. The MIRD model offers patientspecific dosimetry and is useful for routine Y-90 microsphere dosimetry calculations.
